维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

10篇 您的检索式：作者名="Cesare Cuspidi"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Resistant hypertension and left ventricular hypertrophy: an overview显示文摘	Cesare Cuspidi Alvaro Vaccarella Francesca Negri Carla Sala	2010	Journal of the American Society of Hypertension2010，，6：	2
	2	Does the metabolic syndrome impact left-ventricular mechanics? A two-dimensional speckle tracking study显示文摘	Marijana Tadic Cesare Cuspidi Anka Majstorovic Biljana Pencic Sladjana Backovic Branislava Ivanovic Radisav Scepanovic Jelena Martinov Vesna Kocijancic Vera Celic	2014	Journal of Hypertension2014，，：	1
	3	Left Ventricular Mechanics in Untreated Normotensive Patients with Type 2 Dia- betes Speckle Tracking Study显示文摘	Marijana Tadic Sanja llic Cesare Cuspidi	2014	Wiley Periodicals2014，10，11：	1
	4	Association of left atrial enlargement with left ventricular hypertrophy and diastolic dysfunction: A tissue Doppler study in echocardiographic practice显示文摘	Cesare Cuspidi Francesca Negri Carla Sala Cristiana Valerio Giuseppe Mancia	2012	Blood Pressure2012，，1：	1
	5	Metabolic syndrome and target organ damage in untreated essential hypertensives显示文摘	Cesare Cuspidi Stefano Meani Veronica Fusi	2004	Journal of Hypertension2004，22，10：	1
	6	Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality显示文摘	Michele Bombelli Irene Ronchi Marco Volpe Rita Facchetti Stefano Carugo Raffaella Dell’Oro Cesare Cuspidi Guido Grassi Giuseppe Mancia	2014	Journal of Hypertension2014，，6：	1
	7	Long-Term Control of Arterial Hypertension and Regression of Left Ventricular Hypertrophy With Treatment of Primary Aldosteronism显示文摘	Gian Paolo Rossi Maurizio Cesari Cesare Cuspidi Giuseppe Maiolino Maria Verena Cicala Valeria Bisogni Franco Mantero Achille C. Pessina	2013	Hypertension2013，，1：	1
	8	Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality显示文摘	Michele Bombelli Irene Ronchi Marco Volpe Rita Facchetti Stefano Carugo Raffaella Dell’Oro Cesare Cuspidi Guido Grassi Giuseppe Mancia	2014	Journal of Hypertension2014，，：	1
	9	Prevalence of home blood pressure measurement among selected hypertensive patients: Results of a multicenter survey from six hospital outpatient hypertension clinics in Italy显示文摘	Cesare Cuspidi Stefano Meani Laura Lonati Veronica Fusi Gaia Magnaghi Guido Garavelli Gaetana Palumbo Claudio Pini Alvaro Vaccarella Gianfranco Parati Gastone Leonetti Alberto Zanchetti Cesare Cuspidi Stefano Meani Laura Lonati Veronica Fusi Gaia Magnaghi	2005	Blood Pressure2005，，4：	1
	10	Antihypertensive Effect of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide 1 Receptor Agonists显示文摘An increasing body of evidence shows that new antidiabetic drugs—particularly sodium-glucose cotransporter 2(SGLT2)inhibitors and glucagon-like peptide 1(GLP-1)receptor agonists—have a beneficial effect on cardiovascular outcome.The majority of these studies have been performed in patients with heart failure and the results have shown first positive effect on blood pressure(BP)reduction.These effects are more pronounced with SGLT2 inhibitors than with GLP-1 receptor agonists.However,the reasons and mechanisms of action inducing BP reduction are still not sufficiently clear.Proposed mechanisms of SGLT2 inhibitors involve the natriuretic effect,modification of the renin-angiotensin-aldosterone system,and/or the reduction in the sympathetic nervous system.GLP-1 receptor agonists have several mechanisms that are related to glycemic,weight,and BP control.Current data show that SGLT2 inhibitors have a stronger antihypertensive effect than GLP-1 receptor agonists,which is mainly related to their renal effect.Briefly,SGLT2 inhibitors increase the response to diuretics and decrease the meal-related antinatriuretic pressure by lowering post-prandial hyperglycemia and hyperinsulinemia and prevent proximal sodium reabsorption.SGLT2 inhibitors can be used as second-line therapy in patients with diabetes mellitus or heart disease and concomitant hypertension.This article aims to summarize current knowledge regarding the antihypertensive effect of SGLT2 inhibitors and GLP-1 receptor agonists.	Marijana Tadic Cesare Cuspidi	2024	Cardiology Discovery2024，4，1：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费